Skip to content

e.l.f. Beauty stock

ELFNYSE

e.l.f. Beauty, Inc., Consumer DefensiveISIN US26856L1035

$113.57▼ $4.89 (−4.1%)Closing price of 12 Nov 2026

69Score 69 out of 100, Neutral

Turn on early warning

Price and trend

89 / 100

Price history

+46% in one year

The chart shows daily closes over 10 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 38% above it.

Trend change

Since August 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 49).

Distance to the high

The price is 4.8% below its 52-week high. Largest decline in 10 years: 77% (June 2024 to June 2026).

Chart figures for advanced users
SMA 50$107.11
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$82.42
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)49
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDbelow the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$49.57
The lowest closing price of the last twelve months.
Resistance$119.35
The highest closing price of the last twelve months.
Market cap
$7.01B
Div. yield
no dividend
82.2
on reported earnings of the last twelve months
29.8
on earnings for the next twelve months ($3.98 per share)
Fair value
$36.71

Snapshot

Computed from the data by fixed rules, no AI

  • e.l.f. Beauty, Inc. belongs to the Household & Personal Products industry (United States) and, with a market value of $6.72B, is number 22 of 39 companies in its industry on MEQIRI.
  • In fiscal 2026 it reported revenue of $1.64B (up 24.6% year on year) and earnings of $26.32M (down 76.5%).
  • For fiscal 2027, analysts expect on average revenue of $2.01B (up 22.9%) and adjusted earnings per share of $3.80 (up 21.5%).
Show more
  • MEQIRI Score 69 out of 100 (Neutral): rank 75 of 295 in Consumer Defensive, median 62.
  • The P/E is 78.8 (Household & Personal Products median 23.9, own median of recent years 45.8).
  • Our model puts fair value at $36.71, with the price 223% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Growing faster than its industryRevenue up 38.8% a year since 2021, Household & Personal Products median 4.3%.Growth 100
  • Earnings turn into cashFree cash flow 318% of earnings over the last 12 months.Fundamentals 84
  • Earnings per share growingUp 28.2% a year since 2021.Growth 100

Weaknesses

  • Above fair valuePrice 223% above the fair value of $36.71.Valuation 13
  • Richly valuedP/E 78.8, Household & Personal Products median 23.9, own median 45.8.Valuation 13
  • DilutionShare count up 18% since 2021.Capital allocation 36
69/ 100
MEQIRI Score
Neutral

Its standout strengths are growth and momentum, while capital allocation and valuation hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 68 to 69.

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)318%
ROIC (12 months)8.4%
Positive free cash flow90% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • high price swings
  • high growth grade (crashed more often in the backtest)

What lowers it

  • solid fundamentals
  • price near its 52-week high
  • stable momentum

Valuation

Valuation signal

Significantly overvalued
Price
$118.46
Fair value
$36.71
Gap to fair value
+223%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $26.22 and expensive above $61.18 (uncertainty high, based on the price swings of the past year).

The two parts of the fair value come to $39.03 (cash-flow model) and $34.39 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $33.42, at 7.8% it would be $41.63.

Valuation metrics

9.47
27.9
Fair value (model)
$36.71
Earnings part $34.39 (earnings per share $1.44 × 23.9)

Half from the cash-flow model, half from earnings times the industry P/E (23.9).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

12 years

In the twelve months to 30 Sep 2026, revenue rose 39.9% on the twelve months before. Revenue has grown strongly since 2014, at around 25% per year.

Margins

12 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2026: gross 71%, operating 8%, net 2%.

Debt & balance sheet

latest quarter
0.74
2x
2.57
Cash & equivalents
$350.8M

Debt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
3 Feb 2027in 83 days
Last reported
4 Nov 2026EPS reported $1.21 (expected $0.60)above expectations

Analyst estimates

Analysts have raised their 2028 earnings estimate by 5.8% since 15 Oct 2026.

Fiscal 20279 analysts
Earnings per share
$3.80+4.7%
Revenue
$2.01B+2.1%
Fiscal 202815 analysts
Earnings per share
$4.09+5.8%
Revenue
$2.19B+2.5%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook raised

Share price after the results: +5.1%

Outlook raised: net sales growth of 18% to 20% (previously 12% to 14%), adjusted EBITDA of $401 million to $407 million (previously $379 million to $385 million).

Supporting passage from the call, verbatim
“From a profitability perspective, we now expect adjusted EBITDA of $401 million to $407 million in fiscal '27, growing 20% to 21% year-over-year, up from the $379 million to $385 million or 13% to 15% growth previously.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 5 Aug 2026 (fiscal Q1 2027), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. 7 insiders sold, $22.63M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Franks Joshua AllenSale

    5 Nov 2026, SVP, Operations

    Shares
    8,965
    Price
    $120.47
    Value
    $1.08M
  • Franks Joshua AllenSale

    15 Oct 2026, SVP, Operations

    Shares
    7,926
    Price
    $110.15
    Value
    $873,072
  • Franks Joshua AllenSale

    12 Oct 2026, SVP, Operations

    Shares
    8,366
    Price
    $110.01
    Value
    $920,310
Show 22 more
  • Amin TarangSale

    1 Oct 2026, Chief Executive Officer

    Shares
    47,000
    Price
    $103.31
    Value
    $4.86M
  • Fields Mandy JSale

    8 Sept 2026, See Remarks

    Shares
    16,065
    Price
    $104.52
    Value
    $1.68M
  • Franks Joshua AllenSale

    8 Sept 2026, SVP, Operations

    Shares
    200
    Price
    $110.00
    Value
    $22,000
  • Franks Joshua AllenSale

    1 Sept 2026, SVP, Operations

    Shares
    5,512
    Price
    $110.00
    Value
    $606,320
  • Franks Joshua AllenSale

    19 Aug 2026, SVP, Operations

    Shares
    5,718
    Price
    $100.00
    Value
    $571,800
  • Levitan Lauren CooksSale

    18 Aug 2026, Board

    Shares
    1,034
    Price
    $93.15
    Value
    $96,321
  • Marchisotto KorySale

    4 Aug 2026, See Remarks

    Shares
    12,173
    Price
    $88.02
    Value
    $1.07M
  • Hartnett Jennifer CatherineSale

    1 Jul 2026, Chief Commercial Officer

    Shares
    25,357
    Price
    $80.00
    Value
    $2.03M
  • Amin TarangSale

    1 Jul 2026, Chief Executive Officer

    Shares
    50,164
    Price
    $78.24
    Value
    $3.92M
  • Amin TarangSale

    9 Jun 2026, Chief Executive Officer

    Shares
    7,000
    Price
    $51.53
    Value
    $360,710
  • Hartnett Jennifer CatherineSale

    9 Jun 2026, Chief Commercial Officer

    Shares
    4,352
    Price
    $51.53
    Value
    $224,259
  • Franks Joshua AllenSale

    9 Jun 2026, SVP, Operations

    Shares
    3,505
    Price
    $51.53
    Value
    $180,613
  • Fields Mandy JSale

    9 Jun 2026, See Remarks

    Shares
    4,327
    Price
    $51.53
    Value
    $222,970
  • Marchisotto KorySale

    9 Jun 2026, See Remarks

    Shares
    4,352
    Price
    $51.53
    Value
    $224,259
  • Milsten ScottSale

    9 Jun 2026, Insider

    Shares
    4,162
    Price
    $51.53
    Value
    $214,468
  • Amin TarangSale

    4 Jun 2026, Chief Executive Officer

    Shares
    15,829
    Price
    $51.94
    Value
    $822,158
  • Hartnett Jennifer CatherineSale

    4 Jun 2026, Chief Commercial Officer

    Shares
    10,318
    Price
    $51.94
    Value
    $535,917
  • Franks Joshua AllenSale

    4 Jun 2026, SVP, Operations

    Shares
    6,854
    Price
    $51.94
    Value
    $355,997
  • Fields Mandy JSale

    4 Jun 2026, See Remarks

    Shares
    8,464
    Price
    $51.94
    Value
    $439,620
  • Marchisotto KorySale

    4 Jun 2026, See Remarks

    Shares
    8,512
    Price
    $51.94
    Value
    $442,113
  • Milsten ScottSale

    4 Jun 2026, Insider

    Shares
    8,512
    Price
    $51.94
    Value
    $442,113
  • Levitan Lauren CooksSale

    28 May 2026, Board

    Shares
    7,714
    Price
    $56.31
    Value
    $434,376

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at e.l.f. Beauty

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

295 rated companies in Consumer Defensive

Rank 75 of 295
75/ 295
This company
69
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies52 (median 54)2 below the median
GrowthMedian of 295 companies100 (median 50)50 above the median
FundamentalsMedian of 295 companies84 (median 79)5 above the median
ValuationMedian of 290 companies with a value13 (median 65)52 below the median
StabilityMedian of 295 companies51 (median 68)17 below the median
Capital allocationMedian of 295 companies36 (median 62)26 below the median
Technical analysisMedian of 295 companies89 (median 65)24 above the median
MomentumMedian of 295 companies94 (median 60)34 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Household & Personal Products

The next larger and next smaller companies by market value

All 39 Household & Personal Products stocks

ETFs that hold e.l.f. Beauty

Held by 10 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 31 Mar 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Oct 2025)
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy